Ophthalmic Epidemiology Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Optometry, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Arch Iran Med. 2020 Jul 1;23(7):445-454. doi: 10.34172/aim.2020.41.
To describe the protocol for developing a national inherited retinal disease (IRD) registry in Iran and present its initial report.
This community-based participatory research was approved by the Ministry of Health and Medical Education of Iran in 2016. To provide the minimum data set (MDS), several focus group meetings were held. The final MDS was handed over to an engineering team to develop a web-based software. In the pilot phase, the software was set up in two referral centers in Iran. Final IRD diagnosis was made based on clinical manifestations and genetic findings. Ultimately, patient registration was done based on all clinical and non-clinical manifestations.
Initially, a total of 151 data elements were approved with Delphi technique. The registry software went live at www. IRDReg.org based on DHIS2 open source license agreement since February 2016. So far, a total of 1001 patients have been registered with a mean age of 32.41±15.60 years (range, 3 months to 74 years). The majority of the registered patients had retinitis pigmentosa (42%, 95% CI: 38.9% to 45%). Genetic testing was done for approximately 20% of the registered individuals.
Our study shows successful web-based software design and data collection as a proof of concept for the first IRD registry in Iran. Multicenter integration of the IRD registry in medical centers throughout the country is well underway as planned. These data will assist researchers to rapidly access information about the distribution and genetic patterns of this disease.
描述伊朗国家遗传性视网膜疾病(IRD)登记处的制定方案,并呈现其初步报告。
本项以社区为基础的参与式研究于 2016 年获得伊朗卫生部和医疗教育部的批准。为了提供最小数据集(MDS),举行了几次焦点小组会议。最终的 MDS 被移交给一个工程团队,以开发一个基于网络的软件。在试点阶段,该软件在伊朗的两个转诊中心设立。最终的 IRD 诊断是基于临床表现和基因发现。最终,根据所有临床和非临床症状对患者进行登记。
最初,通过德尔菲技术批准了总共 151 个数据项。该登记软件自 2016 年 2 月以来,根据 DHIS2 开源许可协议在 www.IRDReg.org 上线。到目前为止,已有 1001 名患者登记,平均年龄为 32.41±15.60 岁(范围:3 个月至 74 岁)。登记的患者中大多数患有色素性视网膜炎(42%,95%CI:38.9%至 45%)。约 20%的登记患者进行了基因检测。
我们的研究表明,成功设计了基于网络的软件并进行了数据收集,这为伊朗首个 IRD 登记处提供了概念验证。正如计划的那样,正在全国各医疗中心多中心整合 IRD 登记处。这些数据将帮助研究人员快速获取有关该疾病分布和遗传模式的信息。